Aug 24 (Reuters) - Acrux Ltd (ACR) : Acrux and Eli Lilly to...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Aug 24 (Reuters) - Acrux Ltd (ACR) :

    • Acrux and Eli Lilly to appeal patent ruling on axiron (ACR)
    • Says "decision allows FDA-approved generic versions of axiron to enter the

      U.S. marketplace "at risk," pending an appeal"

    • Says Lilly and Acrux continue to believe that the axiron formulation and

      axilla application patents are valid and enforceable

                            
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.5¢
Change
0.001(3.57%)
Mkt cap ! $5.934M
Open High Low Value Volume
1.5¢ 1.5¢ 1.5¢ $190 13.11K

Buyers (Bids)

No. Vol. Price($)
4 2718844 1.4¢
 

Sellers (Offers)

Price($) Vol. No.
1.5¢ 366911 3
View Market Depth
Last trade - 13.02pm 11/09/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.